The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Disulfide bond structures of IgG molecules: Structural variations, chemical modifications and possible impacts to stability and biological function
Open accessAbstract
The disulfide bond structures established decades ago for immunoglobulins have been challenged by findings from extensive characterization of recombinant and human monoclonal IgG antibodies. Non-classical disulfide bond structure was first identified in IgG4 and later in IgG2 antibodies. Although, cysteine residues should be in the disulfide bonded states, free sulfhydryls have been detected in all subclasses of IgG antibodies. In addition, disulfide bonds are susceptible to chemical modifications, which can further generate structural variants such as IgG antibodies with trisulfide bond or thioether linkages. Trisulfide bond formation has also been observed for IgG of all subclasses. Degradation of disulfide bond through β-elimination generates free sulfhydryls disulfide and dehydroalanine. Further reaction between free sulfhydryl and dehydroalanine leads to the formation of a non-reducible cross-linked species. Hydrolysis of the dehydroalanine residue contributes substantially to antibody hinge region fragmentation. The effect of these disulfide bond variations on antibody structure, stability and biological function are discussed in this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anti-Inflammatory Activity of Human IgG4 Antibodies by Dynamic Fab Arm Exchange
van der Neut Kolfschoten, M., Schuurman, J., Losen, M., Bleeker, W. K., Martínez-Martínez, P., Vermeulen, E., den Bleker, T. H., Wiegman, L., Vink, T., Aarden, L. A., et al. (2007) · Science · doi:10.1126/science.1144603 · Cited by 975
THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULE
Edelman, G. M., Cunningham, B. A., Gall, W. E., Gottlieb, P. D., Rutishauser, U., & Waxdal, M. J. (1969) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.63.1.78 · Cited by 901
Lefranc, M.-P., Pommié, C., Ruiz, M., Giudicelli, V., Foulquier, E., Truong, L., Thouvenin-Contet, V., & Lefranc, G. (2003) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(02)00039-3 · Cited by 818
Lefranc, M.-P., Pommié, C., Kaas, Q., Duprat, E., Bosc, N., Guiraudou, D., Jean, C., Ruiz, M., Da Piédade, I., Rouard, M., et al. (2005) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2004.07.003 · Cited by 807
Three-Dimensional Structure of Immunoglobulins
Amzel, L. M., & Poljak, R. J. (1979) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.48.070179.004525 · Cited by 692
Immunoglobulin G: Functional sites
Burton, D. R. (1985) · Molecular Immunology · doi:10.1016/0161-5890(85)90151-8 · Cited by 433
Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass
Dillon, T. M., Ricci, M. S., Vezina, C., Flynn, G. C., Liu, Y. D., Rehder, D. S., Plant, M., Henkle, B., Li, Y., Deechongkit, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709988200 · Cited by 291
Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms
Wypych, J., Li, M., Guo, A., Zhang, Z., Martinez, T., Allen, M. J., Fodor, S., Kelner, D. N., Flynn, G. C., Liu, Y. D., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709987200 · Cited by 286
A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody
Angal, S., King, D. J., Bodmer, M. W., Turner, A., Lawson, A. D. G., Roberts, G., Pedley, B., & Adair, J. R. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90432-b · Cited by 245
van der Zee, J. S., van Swieten, P., & Aalberse, R. C. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.137.11.3566 · Cited by 184
Immunoglobulins: Structural Studies of Immunoglobulin G
FRANGIONE, B., MILSTEIN, C., & PINK, J. R. L. (1969) · Nature · doi:10.1038/221145a0 · Cited by 176
The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds
Schuurman, J., Perdok, G. J., Gorter, A. D., & Aalberse, R. C. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00050-5 · Cited by 174
Degradation of protein disulphide bonds in dilute alkali
Florence, T. M. (1980) · Biochemical Journal · doi:10.1042/bj1890507 · Cited by 164
Effects of alkali on proteins. Disulfides and their products
Nashef, A. S., Osuga, D. T., Lee, H. S., Ahmed, A. I., Whitaker, J. R., & Feeney, R. E. (1977) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf60210a020 · Cited by 154
Liu, H., Chumsae, C. M., Gaza‐Bulseco, G., Hurkmans, K., & Radziejewski, C. H. (2010) · Analytical Chemistry · doi:10.1021/ac100575n · Cited by 154
Self-citationCohen, S. L., Price, C. E., & Vlasak, J. (2007) · Journal of the American Chemical Society · doi:10.1021/ja0705994 · Cited by 150
Normal human immunoglobulin G4 is bispecific: it has two different antigen‐combining sites
Schuurman, J., van Ree, R., Perdok, G. J., van Doorn, H. R., Tan, K. Y., & Aalberse, R. C. (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00845.x · Cited by 148
Heterogeneity of recombinant antibodies: linking structure to function.
Harris, R. (2005) · PubMed · Cited by 141
Goto, Y., & HAMAGUCHI, K. (1979) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a132661 · Cited by 137
A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding
Proba, K., Honegger, A., & Plückthun, A. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0726 · Cited by 132
Human IgG2 Can Form Covalent Dimers
Yoo, E. M., Wims, L. A., Chan, L. A., & Morrison, S. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3134 · Cited by 126
Intrachain disulfide bond in the core hinge region of human IgG4
Bloom, J. W., Madanat, M. S., Marriott, D., et al. (1997) · Protein Science · doi:10.1002/pro.5560060217 · Cited by 125
Characterization of antibody aggregation: Role of buried, unpaired cysteines in particle formation
Brych, S. R., Gokarn, Y. R., Hultgen, H., Stevenson, R., Rajan, R. S., & Matsumura, M. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21868 · Cited by 119
Chaderjian, W. B., Chin, E. T., Harris, R. J., & Etcheverry, T. (2005) · Biotechnology Progress · doi:10.1021/bp0497029 · Cited by 118
Human IgG2 Antibody Disulfide Rearrangement in Vivo
Liu, D., Chen, X., Enk, J. Z.-V., Plant, M., Dillon, T. M., & Flynn, G. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804787200 · Cited by 116
McNabb, T. C., Koh, T. Y., Dorrington, K. J., & Painter, R. H. (1976) · PubMed · Cited by 114
Tous, G. I., Wei, Z., Feng, J., Bilbulian, S., Bowen, S., Smith, J., Strouse, R., McGeehan, P., Casas‐Finet, J. R., & Schenerman, M. A. (2005) · Analytical Chemistry · doi:10.1021/ac0500582 · Cited by 113
McAuley, A., Jacob, J., Kolvenbach, C. G., Westland, K., Lee, H. J., Brych, S. R., Rehder, D. S., Kleemann, G. R., Brems, D. N., & Matsumura, M. (2007) · Protein Science · doi:10.1110/ps.073134408 · Cited by 110
Colcher, D. M., Milenic, D. E., Roselli, M., Raubitschek, A. A., Yarranton, G. T., Griffiths-King, D. J., Adair, J. R., Whittle, N., Bodmer, M., & Schlom, J. (1989) · PubMed · Cited by 107
Characterization of trisulfide modification in antibodies
Gu, S., Wen, D., Weinreb, P. H., Sun, Y., Zhang, L., Foley, S. F., Kshirsagar, R., Evans, D. R., Mi, S., Meier, W., et al. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.01.019 · Cited by 107
Frangione, B., & Milstein, C. (1968) · Journal of Molecular Biology · doi:10.1016/0022-2836(68)90326-4 · Cited by 99
Folding and association of the antibody domain CH3: prolyl isomerization preceeds dimerization
Thies, M., Mayer, J., Augustine, J. G., Frederick, C., Lilie, H., & Büchner, J. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3128 · Cited by 85
Franey, H., Brych, S. R., Kolvenbach, C. G., & Rajan, R. S. (2010) · Protein Science · doi:10.1002/pro.434 · Cited by 82
Structure and Function of Immunoglobulin Domains
McNabb, T. C., Koh, T. Y., Dorrington, K. J., & Painter, R. H. (1976) · The Journal of Immunology · doi:10.4049/jimmunol.117.3.882 · Cited by 82
Evidence for Trisulfide Bonds in a Recombinant Variant of a Human IgG2 Monoclonal Antibody
Pristatsky, P., Cohen, S. L., Krantz, D., Acevedo, J., Ionescu, R. M., & Vlasak, J. (2009) · Analytical Chemistry · doi:10.1021/ac9006254 · Cited by 81
Disulfide Connectivity of Human Immunoglobulin G2 Structural Isoforms
Martinez, T., Guo, A. X., Allen, M. J., Han, M., Pace, D. L., Jones, J. B., Gillespie, R., Ketchem, R. R., Zhang, Y., & Balland, A. (2008) · Biochemistry · doi:10.1021/bi800576c · Cited by 80
Functional antibody lacking a variable-region disulfide bridge.
Rudikoff, S., & Pumphrey, J. G. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.20.7875 · Cited by 79
King, D. J., Adair, J. R., Angal, S., Low, D. C., Proudfoot, K. A., Lloyd, J. C., Bodmer, M., & Yarranton, G. T. (1992) · Biochemical Journal · doi:10.1042/bj2810317 · Cited by 78
Liu, H., Gaza‐Bulseco, G., Chumsae, C. M., & Newby‐Kew, A. (2007) · Biotechnology Letters · doi:10.1007/s10529-007-9449-8 · Cited by 76
Self-citationPetersen, J. G. L., & Dorrington, K. J. (1974) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)79774-7 · Cited by 74
Ouellette, D., Alessandri, L., Chin, A. T., Grinnell, C. M., Tarcsa, E., Radziejewski, C. H., & Correia, I. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.09.027 · Cited by 73
Active dimer of Epratuzumab provides insight into the complex nature of an antibody aggregate
Remmele, R. L., Callahan, W. J., Krishnan, S., Zhou, L., Bondarenko, P. V., Nichols, A. C., Kleemann, G. R., Pipes, G. D., Park, S., Fodor, S., et al. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20515 · Cited by 64
Nielsen, R. W., Tachibana, C., Hansen, N. E., & Winther, J. R. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3677 · Cited by 63
Michaelsen, T. E., Wislöff, F., & Natvig, J. B. (1975) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1975.tb02601.x · Cited by 62
Understanding base‐assisted desulfurization using a variety of disulfide‐bridged peptides
Galande, A. K., Trent, J. O., & Spatola, A. F. (2003) · Biopolymers · doi:10.1002/bip.10532 · Cited by 62
Inter Heavy–Light Chain Disulphide Bridge in Immune Globulins
Pink, J. R. L., & Milstein, C. (1967) · Nature · doi:10.1038/214092a0 · Cited by 48
Intrachain disulphide bridges in immunoglobulin G heavy chains. The Fc fragment
Frangione, B., Milstein, C., & Franklin, E. C. (1968) · Biochemical Journal · doi:10.1042/bj1060015 · Cited by 48
Xiang, T., Chumsae, C. M., & Liu, H. (2009) · Analytical Chemistry · doi:10.1021/ac901311y · Cited by 44
Self-citationDisulfide Scrambling in IgG2 Monoclonal Antibodies: Insights from Molecular Dynamics Simulations
Wang, X., Kumar, S., & Singh, S. K. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0503-9 · Cited by 44
Binding Site of Human IgG Subclasses and Their Domains for Fc Receptors of Activated Murine T Cells
Klein, M., Sautès‐Fridman, C., Ellerson, J. R., & Fridman, W. H. (1977) · The Journal of Immunology · doi:10.4049/jimmunol.119.3.1077 · Cited by 39
Michaelsen, T. E., Næss, L. M., & Aase, A. (1993) · Molecular Immunology · doi:10.1016/0161-5890(93)90424-a · Cited by 17
Cited by
Site-selective modification strategies in antibody–drug conjugates
Walsh, S. J., Bargh, J. D., Dannheim, F. M., Hanby, A. R., Seki, H., Counsell, A. J., Ou, X., Fowler, E., Ashman, N., Takada, Y., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00310g · Cited by 461
Higel, F., Seidl, A., Sörgel, F., & Friess, W. (2016) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2016.01.005 · Cited by 360
IgG Fc engineering to modulate antibody effector functions
Wang, X., Mathieu, M., & Brezski, R. J. (2018) · Protein & Cell · doi:10.1007/s13238-017-0473-8 · Cited by 356
Functionalizing nanoparticles with cancer-targeting antibodies: A comparison of strategies
Marques, A. C., Costa, P. J., Velho, S., & Amaral, M. H. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.01.035 · Cited by 349
Considerations for the Design of Antibody-Based Therapeutics
Goulet, D. R., & Atkins, W. M. (2020) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2019.05.031 · Cited by 302
Metadata
- Authors
- Liu, H., & May, K.
- Venue
- mAbs
- Publisher
- Informa UK Limited
- Published
- 2012-01
- Volume
- 4
- Issue
- 1
- Pages
- 17-23
- ISSN
- 1942-0862 (ISSN-L)
- 1942-0870
- OpenAlex
- W1555361166
- Cited by
- 484
- References
- 51
- FWCI
- 15.58
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.